The Vanguard Group Discloses Interest in Mural Oncology

The Vanguard Group, Inc. has released a disclosure under the Irish Takeover Panel's rule 8.3, detailing its current interests in Mural Oncology plc. As of October 2, 2025, Vanguard holds a notable position, comprising 1.67% of Mural Oncology's $0.01 ordinary shares, totaling 288,459 securities.

The disclosure indicates that Vanguard purchased 96 shares at a unit price of $2.07. No cash-settled or stock-settled derivatives, options, or other agreements were reported. Additionally, there are no indemnity or other dealing arrangements disclosed by Vanguard.

This report follows procedural norms for those holding over 1% of relevant securities under the Irish Takeover Panel Act, 1997. The form serves as a transparent measure for monitoring major shareholders' actions and their influence over company control.